Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
about
The Fibroblast Growth Factor signaling pathwayTargeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma.Sperm-associated antigen 9 is upregulated in hepatocellular carcinoma tissue and enhances QGY cell proliferation and invasion in vitro.Effect of obeticholic acid on liver regeneration following portal vein embolization in an experimental model.Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?N'-Alkylaminosulfonyl Analogues of 6-Fluorobenzylideneindolinones with Desirable Physicochemical Profiles and Potent Growth Inhibitory Activities on Hepatocellular Carcinoma.FXR, intestinal FiXeR of hepatocellular carcinoma?
P2860
Q34467171-78D6641E-1AD1-40D4-B323-10C0898D1BF2Q38303270-A0C4558D-AE44-4ABE-8C80-76D429EFA2B2Q42343453-26D87D00-E08E-47DC-B999-08236E3EC378Q49386963-FCC2DDEB-19BF-4452-90E2-0E3F38E4FFF9Q51138526-EF75F1CB-C205-4A73-8EF0-D28EDB9EC5F3Q52926888-5875B530-085C-4D3F-B38D-1742A7E6E45DQ53406680-FC299E1E-71D4-4E07-8461-6BC401851181Q57147758-2E8161AA-8932-4351-9275-3B7C8A8D198B
P2860
Fibroblast growth factor receptor 4: a putative key driver for the aggressive phenotype of hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Fibroblast growth factor recep ...... e of hepatocellular carcinoma.
@en
type
label
Fibroblast growth factor recep ...... e of hepatocellular carcinoma.
@en
prefLabel
Fibroblast growth factor recep ...... e of hepatocellular carcinoma.
@en
P2093
P2860
P50
P356
P1433
P1476
Fibroblast growth factor recep ...... pe of hepatocellular carcinoma
@en
P2093
Bettina Grasl-Kraupp
Brigitte Marian
Christine Gauglhofer
Christine Heinzle
Daniela Huber
Jakob Paur
Rolf Schulte-Hermann
P2860
P304
P356
10.1093/CARCIN/BGU151
P407
P50
P577
2014-07-16T00:00:00Z